Astera Labs, Inc. (NASDAQ:ALAB) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Astera Labs, Inc. (NASDAQ:ALAB) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-four analysts that are currently covering the company, MarketBeat reports. Eight equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $188.1667.

Several equities research analysts have weighed in on ALAB shares. Barclays reiterated an “equal weight” rating and issued a $155.00 target price on shares of Astera Labs in a report on Monday, October 20th. Morgan Stanley reissued an “overweight” rating and set a $210.00 target price on shares of Astera Labs in a research report on Wednesday, December 3rd. Roth Capital boosted their price target on shares of Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Zacks Research downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Finally, Northland Securities increased their target price on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th.

Insider Activity at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 150,000 shares of Astera Labs stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the transaction, the director owned 1,574,498 shares in the company, valued at $261,650,077.64. The trade was a 8.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Sanjay Gajendra sold 90,459 shares of the business’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the transaction, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at $231,467,827.50. This represents a 5.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 576,936 shares of company stock valued at $87,409,540 over the last 90 days. Company insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. American Century Companies Inc. grew its holdings in Astera Labs by 46.9% in the first quarter. American Century Companies Inc. now owns 6,783 shares of the company’s stock worth $405,000 after purchasing an additional 2,165 shares during the last quarter. State of Wyoming purchased a new stake in shares of Astera Labs during the 1st quarter valued at $154,000. Vident Advisory LLC acquired a new stake in shares of Astera Labs in the 1st quarter worth $207,000. Royal Bank of Canada grew its stake in Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares during the last quarter. Finally, PDT Partners LLC increased its position in Astera Labs by 112.3% during the 1st quarter. PDT Partners LLC now owns 53,157 shares of the company’s stock valued at $3,172,000 after buying an additional 28,121 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

Astera Labs stock opened at $170.84 on Wednesday. The stock has a market cap of $28.85 billion, a price-to-earnings ratio of 153.91, a price-to-earnings-growth ratio of 3.17 and a beta of 1.51. The firm has a 50-day moving average of $160.32 and a two-hundred day moving average of $159.75. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same period last year, the company posted $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Research analysts expect that Astera Labs will post 0.34 earnings per share for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.